Search for: "Sandoz, Inc"
Results 581 - 600
of 679
Sort by Relevance
|
Sort by Date
27 Aug 2009, 7:43 am
Sandoz, Inc., 544 F.3d 1341, 1352 (Fed. [read post]
26 Aug 2009, 5:14 pm
Sandoz, Inc., 544 F.3d 1341, 1352 (Fed. [read post]
9 Aug 2009, 4:54 pm
Sandoz Inc. v. [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
21 Jul 2009, 9:28 pm
District Court for the Central District of California denied Sandoz Inc.'s motion seeking attorneys' fees and costs in its patent infringement suit with Sanofi-Aventis. [read post]
15 Jul 2009, 5:15 am
IPAB rejects Novartis’ patent application for Glivec (Intellectual Property Watch) Lescol (Fluvastatin) – Netherlands: No interim relief pending appeal against invalidity, rules District Court of The Hague: Novartis v Mylan and Actavis (PatLit) Levaquin (Levoflaxacin) – Canada: FCA holds generics raising allegations similar to those of previous generics allowed their day in court: Apotex v Janssen-Ortho (Global IP Watch) Lexapro (Escitalopram) – US: Caraco… [read post]
7 Jul 2009, 5:12 am
” Id., at 7135-36 (citing Sandoz v. [read post]
1 Jul 2009, 7:14 am
(Patent Docs) Products Avapro (Irbesartan) – Spain: Fourth Commercial Court of Barcelona rejects preliminary injunction petition by Sanofi-Aventis and Bristol-Myers Squibb for alleged patent infringement (International Law Office) Cozaar/Hyzaar (Losartan/Hydrochlorothiazide and Losartan) –US: Teva sues FDA over generic Cozaar and Hyzaar 180-day exclusivity forfeiture and patent delisting rule (The FDA Law Blog) Eloxatin (Oxaliplatin) – US: District Court of New Jersey… [read post]
29 Jun 2009, 8:52 pm
Sandoz (Fed. [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s ever changing landscape… [read post]
7 Jun 2009, 9:57 pm
Sandoz, Inc. 1:09-cv-05210; filed June 3, 2009 in the Southern District of New York Infringement of U.S. [read post]
4 Jun 2009, 5:30 am
Sandoz, Inc., a decision that just screams for Congress to codify Rule 56 and settle once and for all the duty of candor that is owed to the Patent Office during the patent application process. [read post]
27 May 2009, 5:38 am
Sandoz, Inc., (Fed. [read post]
25 May 2009, 5:20 pm
(The IP Factor) Israel Patent Office practice regarding legal expenses in oppositions (The IP Factor) New Zealand New Zealand launches second ACTA consultation (Michael Geist) United Kingdom EWHC request for summary judgment denied - OHIM-IPO class heading conflict case: Daimler v Sany (IPKat) United States US General Trade secret litigation on the rise against laid off employees (Silicon Valley IP Licensing Law Blog) Seeking and justifying attorney fee awards may be… [read post]
21 May 2009, 10:03 am
Sandoz, Inc., a decision that just screams for Congress to codify Rule 56 and settle once and for all the duty of candor that is owed to the Patent Office during the patent application process. [read post]
19 May 2009, 7:34 am
Sandoz, Inc., (Fed. [read post]
19 May 2009, 4:23 am
Sandoz, Inc., the Court of Appeals for the Federal Circuit took the opportunity to reconcile a long-standing conflict in its precedent. [read post]
8 May 2009, 8:00 am
(Property intangible) US: Supreme Court rules 9-0 that CAFC has jurisdiction to review case remanded by district court to state court: Carlsbad Technology Inc v HIF Bio, Inc et al (Managing Intellectual Property) (Patently-O) US: Anticipation by a laundry list of prophetic DNA sequences: In re Gleave (Holman's Biotech IP Blog) US: Reverse payment settlements and biotechnology (Holman's Biotech IP Blog) US: Biogen seeks review and correction of patent term adjustment… [read post]
7 May 2009, 6:08 am
Sandoz Pharmaceuticals Corp., 188 F. [read post]
15 Apr 2009, 8:56 pm
., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic version of Razadyne ® ER. [read post]
